Recursion Pharmaceuticals (RXRX) Prepaid Assets (2020 - 2026)

Recursion Pharmaceuticals has reported Prepaid Assets for 7 years, with the latest figure at $11.7 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets fell 63.33% year-over-year to $11.7 million; the trailing twelve-month figure through Mar 2026 stood at $11.7 million (down 63.33% YoY), and the FY2025 full-year result was $11.7 million, down 60.33% from the prior year.
• Prepaid Assets for Q1 2026 stood at $11.7 million, roughly flat from $11.7 million in the prior quarter.
• The five-year high for Prepaid Assets was $43.7 million in Q2 2024, with the low at $11.7 million in Q4 2025.
• Historically, Prepaid Assets has averaged $25.5 million across 5 years, with a median of $18.8 million in 2023.
• Annual changes were most pronounced in 2022 — Prepaid Assets surged 488.78% — and 2026, when it sank 63.33%.
• Recursion Pharmaceuticals' Prepaid Assets stood at $15.9 million in 2022, then jumped by 153.62% to $40.2 million in 2023, then fell by 26.45% to $29.6 million in 2024, then sank by 60.33% to $11.7 million in 2025, then changed by 0.0% to $11.7 million in 2026.
• The last three Prepaid Assets figures came in at $11.7 million (Q1 2026), $11.7 million (Q4 2025), and $29.2 million (Q3 2025), per Business Quant data.